We are living in a time of tremendous health care innovation - from the use of generative AI to precision medicine. Treatments are being developed that meaningfully change the trajectory of life-altering or threatening diseases, including curative gene therapies.
But science only goes so far. Policymakers, governments and health insurance companies should keep pace with scientific advancement so Americans can afford these innovative treatments as they become available.
Read more: Richard Burr: Insurance coverage for obesity allows patients to benefit from science
